+498,251.9%
NVDA vs SBAC
+2,188.2%
+496,063.7%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.3% | -1.2% | -3.2% | -4.0% |
| 7D | -8.5% | -2.7% | -5.8% | -7.9% |
| 30D | -27.3% | +3.3% | -30.6% | -28.1% |
| 3M | -25.8% | +3.3% | -29.0% | -26.7% |
| 6M | -24.6% | -10.9% | -13.6% | -23.2% |
| YTD | -10.7% | -1.0% | -9.7% | -12.4% |
| 1Y | -14.0% | -4.5% | -9.6% | -15.0% |
| 3Y | +244.9% | -8.7% | +253.6% | +234.1% |
| 5Y | +449.3% | -40.6% | +489.9% | +494.7% |
| 10Y | +7,600.6% | +109.4% | +7,491.1% | +5,995.4% |
| All | +498,251.9% | +2,188.2% | +496,063.7% | +186,927.4% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling